Histogen news

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • suruchipurimakeovers
    replied
    Nice Information.

    Leave a comment:


  • Swooping
    replied
    Originally posted by Plain
    I agree with you 100%. I'm sick and tired of constantly clicking click-bait articles with titles like "Cure for MPB closer Scientists find". Not only is it mentally taxing but it's eating up my time when it could be used to come to terms with this genetic death sentence. If Histogen and Replicel fail, I'm done. No more. Zilch. Nada. I will succumb to this disease with bitter resignation.
    They never failed though.. Histogen showed around 7% average growth, and Replicel around 6% till now. That is including female patients in their trials.

    Leave a comment:


  • Gerhard
    replied
    Is Histogen indeed dead?

    Leave a comment:


  • FearTheLoss
    replied
    All signs point to histogen being dead. I hate to say it, but I don't think they got the funding they needed. They were supposed to be starting phase IIb trials already.

    Leave a comment:


  • Reign
    replied
    I emailed them about a week ago asking exactly where they are right now and did not hear back.

    Leave a comment:


  • KO1
    replied
    Can anybody show what trial Histogen is on? I cannot find on their website any trial info or on clinicaltrials.gov or clinicaltrialsregister.eu

    Leave a comment:


  • Scientalk56
    replied
    Originally posted by Hairismylife
    How do you know the release date?
    Looks like another drug potentially approaches approval, Bim just finished it's data collection and will be(im assuming) releasing it's final results in January according to this trial information: http://clinicaltrials.gov/show/NCT01904721 Now i've heard mixed things with this drug, i've seen people use the weaker

    Leave a comment:


  • Hairismylife
    replied
    Originally posted by Scientalk56
    Bim will publish their results in 2016. (It can be jan 2016 or dec 2016 who knows)
    Im happy though we r not going to wait another 5 years to see their phase 2 results. LOL
    How do you know the release date?

    Leave a comment:


  • Scientalk56
    replied
    Bim will publish their results in 2016. (It can be jan 2016 or dec 2016 who knows)
    Im happy though we r not going to wait another 5 years to see their phase 2 results. LOL

    Leave a comment:


  • rdawg
    replied
    Originally posted by Aik82
    Aderans is dead.
    Replicel: is unclear
    Histogen: delayed by two f***ing years
    Follica: no news


    Is that it? have i forgot someone?

    so for 2015/16 nothing of the horizon? I am gonna be screwd. I don't wanna be bald and i don't wanna take fina for the sides.

    I am so depressed guys.
    youre saying news from like two years ago.

    Aderans was never a good option, Replicel is starting up their next trial so you cant say anything negative or positive there we dont know, histogen has been dead since 2012 and as someone else said Follica's work just got picked up by another company.

    add to that they are making advancements in the stem cell area, BIM just finished phase IIb(im sure we'll hear of results soon) and CB and SM are finishing phase II this year. that's more positive news than ANY previous year, trust me, I've been on here since 2011-12

    Leave a comment:


  • FearTheLoss
    replied
    Originally posted by hellouser
    Follica and Kythera are not related though.
    They are. Kythera is using the exact work from follica. Cots has stated many times that a topical pdg2 would be beneficial for stopping hair loss.

    Leave a comment:


  • brocktherock
    replied
    Is there an official word on Histogen?

    Leave a comment:


  • hellouser
    replied
    Originally posted by FearTheLoss
    Wrong about follica!! Kythera just invested in pdg2 and cots patents! They're going into phase 2 trial the end of this year and phase 3 after as long as results are consistent with their prior studies!
    Follica and Kythera are not related though.

    Leave a comment:


  • FearTheLoss
    replied
    Originally posted by Aik82
    Aderans is dead.
    Replicel: is unclear
    Histogen: delayed by two f***ing years
    Follica: no news

    Wrong about follica!! Kythera just invested in pdg2 and cots patents! They're going into phase 2 trial the end of this year and phase 3 after as long as results are consistent with their prior studies!

    Is that it? have i forgot someone?

    so for 2015/16 nothing of the horizon? I am gonna be screwd. I don't wanna be bald and i don't wanna take fina for the sides.



    I am so depressed guys.
    Wrong about follica!! Kythera just invested in pdg2 and cots patents! They're going into phase 2 trial the end of this year and phase 3 after as long as results are consistent with their prior studies!

    Leave a comment:


  • Aik82
    replied
    Originally posted by hellouser
    No, SkinMedcia's unethical practices pushed back histogen by about TWO YEARS.
    Aderans is dead.
    Replicel: is unclear
    Histogen: delayed by two f***ing years
    Follica: no news


    Is that it? have i forgot someone?

    so for 2015/16 nothing of the horizon? I am gonna be screwd. I don't wanna be bald and i don't wanna take fina for the sides.

    I am so depressed guys.

    Leave a comment:

Working...